US2007243631A1PendingUtilityA1

Determination of concentration of fk778 by competitive immunoassay

Individually held — no corporate assignee on recordPriority: Jan 6, 2006Filed: Jun 29, 2007Published: Oct 18, 2007
Est. expiryJan 6, 2026(expired)· nominal 20-yr term from priority
G01N 33/9493
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and kits for measurement of concentration of FK778 in a biological sample by means of an immunoassay, preferably a competitive immunoassay. In one aspect, the method and kit involve the use of (a) an antibody to FK778 conjugated to a label, e.g., an acridinium label, (b) an antibody to FK778 not conjugated to a label, (c) a solid phase containing an antibody to a first hapten, e.g., a fluorescein hapten, and (d) a bihapten comprising a first hapten and FK778 or an analogue of FK778, e.g., a bihapten comprising a fluorescein hapten and a FK778 hapten. In another aspect, the method and kit involve the use of (a) antibody to FK778, (b) a bihapten comprising FK778 or an analogue of FK778 and a first hapten, e.g., a bihapten comprising the fluorescein hapten and the hapten of FK778 or an analogue of FK778, and (c) a pretreatment reagent.

Claims

exact text as granted — not AI-modified
1 . A kit containing the reagents for carrying out an assay for FK778 comprising (a) a mixture of an antibody to FK778 conjugated to a label and an antibody to FK778 not conjugated to a label, (b) a bihapten comprising a first hapten and FK778 or an analogue of FK778, and (c) a solid phase coupled to an antibody specific for the first hapten.  
   
   
       2 . The kit of  claim 1 , wherein the label comprises a chemiluminescent label.  
   
   
       3 . The kit of  claim 1 , wherein the label comprises an acridinium label.

Join the waitlist — get patent alerts

Track US2007243631A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.